Evra

Evra is a transdermal contraceptive patch containing Ethinylestradiol and Norelgestromin. It is designed to prevent pregnancy by delivering hormones through the skin. This patch is a convenient option for those seeking hormonal birth control.

Evra is primarily used for birth control. The patch releases hormones that prevent ovulation and thicken cervical mucus, making it harder for sperm to reach the egg. It is applied once a week for three weeks, followed by a one-week patch-free period. Evra is often considered for those who prefer a non-daily contraceptive method.

Common effects of Evra may include skin irritation at the application site, breast tenderness, headaches, and nausea. Some users may also experience changes in menstrual bleeding patterns. These effects vary among individuals and typically subside as the body adjusts to the medication.

Evra should be used with caution in individuals with a history of blood clots, high blood pressure, or certain types of cancer. It is important to follow the prescribed application schedule and monitor for any signs of allergic reactions or severe side effects. Regular check-ups with a healthcare provider are recommended.

Evra may interact with certain medications, including those that affect liver enzymes, such as some antibiotics and antifungal drugs. It is advisable to consult a healthcare provider before starting or stopping any new medications while using Evra. Alcohol and smoking may also affect the effectiveness and safety of the patch.